IL-13 receptors and signaling pathways: An evolving web is a research paper published in Journal of Allergy and Clinical Immunology (2003). On theSindex it has a DataRank of 0.963. It has been cited 612 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.963
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: R01AI46652-01A1
MeSH Terms
Additional file 3 of IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes
Additional file 3 of IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes
Additional file 4 of IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes
Additional file 4 of IL13Rα1 protects against rheumatoid arthritis by combating the apoptotic resistance of fibroblast-like synoviocytes
Additional file 1 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 1 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 2 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 2 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 3 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 3 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 4 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 4 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 5 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 5 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 6 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 6 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 7 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 7 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 8 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury
Additional file 8 of Macrophage-based delivery of interleukin-13 improves functional and histopathological outcomes following spinal cord injury